12016626

Source:http://linkedlifedata.com/resource/pubmed/id/12016626

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008976, umls-concept:C0018801, umls-concept:C0181598, umls-concept:C0205088, umls-concept:C0443252, umls-concept:C1524063
pubmed:issue	2
pubmed:dateCreated	2002-5-17
pubmed:abstractText	Implantable left ventricular assist devices (LVADs) have been used primarily as bridges to cardiac transplantation, although some patients have been maintained long term on these devices and a few have recovered enough to be weaned. This trial was designed to evaluate their suitability as long-term myocardial replacement therapy in patients who are ineligible for cardiac transplantation.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/12016626-11794191
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9442138
pubmed:status	PubMed-not-MEDLINE
pubmed:month	Apr
pubmed:issn	1071-9164
pubmed:author	pubmed-author:HuntSharon ASA
pubmed:issnType	Print
pubmed:volume	8
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	59-60
pubmed:dateRevised	2010-8-16
pubmed:year	2002
pubmed:articleTitle	Comment--the REMATCH trial: Long-term use of a left ventricular assist device for end-stage heart failure.
pubmed:affiliation	Stanford, California, USA.
pubmed:publicationType	Journal Article, Comment